▲ BUY
8
/ 10
Conviction
$ Value
$41K
Shares
5,553
Price
$7
Filed
Nov 13
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ 10%+ owner (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Gregoire Sylvie
Title
—
CIK
0001335822
Roles
Director
10% Owner
Transaction Details
Transaction Date
2025-11-12
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,467,131
Footnotes
Shares purchased in open-market transactions. | Shares held jointly by the Reporting Person and her spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors.
Filing Info
Gregoire Sylvie's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | CRVO | A | $0 |
| 2025-11-17 | CRVO | ▲ | $91K |
| 2025-11-17 | CRVO | ▲ | $91K ★ |
| 2025-11-14 | CRVO | ▲ | $13K |
| 2025-11-14 | CRVO | ▲ | $13K |
| 2025-11-13 | CRVO | ▲ | $33K |
| 2025-11-12 | CRVO | ▲ | $41K |
| 2025-06-23 | CRVO | A | $0 |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALAM JOHN J
CEO & President
|
— | — | 2026-02-11 |
| Gregoire Sylvie | — | — | 2026-02-11 |
|
Blackburn Kelly
EVP, Clinical Development
|
— | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |